Xenon Pharmaceuticals (XENE) EBT Margin Growth (3y) (2016 - 2025)

Xenon Pharmaceuticals (XENE) EBT Margin Growth (3y) (2016 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9,237.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 441.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -408.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 363.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Xenon Pharmaceuticals 5.71 Bn 5.71 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 -63,272.00
Sep 30, 2022 -2.83 Mn
Dec 31, 2020 5.05 Mn
Sep 30, 2020 308,907.00
Jun 30, 2020 5.19 Mn
Mar 31, 2020 4.89 Mn
Dec 31, 2019 225,241.00
Sep 30, 2019 149,414.00
Dec 31, 2017 -5.04 Mn
Sep 30, 2017 -329,397.00
Jun 30, 2017 -5.19 Mn
Mar 31, 2017 -4.90 Mn
Dec 31, 2016 -263,383.00
Sep 30, 2016 -180,883.00